Estimating the prevalence of illicit opioid use in New York City using multiple data sources

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  McNeely, Jennifer ^a   Gourevitch, Marc N ^a   Paone, Denise ^b   Shah, Sharmila ^b   Wright, Shana ^a   Heller, Daliah ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Epidemiology; Heroin; Opioids; Prevalence; Substance abuse; Substance use

Indexed keywords

PRESCRIPTION DRUG; STREET DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG DEPENDENCE TREATMENT; EMERGENCY HEALTH SERVICE; FACTUAL DATABASE; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; OPIATE ADDICTION; PREVALENCE; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; DATABASES, FACTUAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; PREVALENCE; STREET DRUGS; SUBSTANCE ABUSE TREATMENT CENTERS; YOUNG ADULT;

EID: 84862257255     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-443     Document Type: Article

References (48)

1. An overview of heroin trends in New York City: Past, present and future. Frank B, Mt Sinai J Med 2000 67 5-6 340 346 11064484
2. Medical complications of substance abuse. Lange WR, White N, Robinson N, Postgrad Med 1992 92 205 214 1518754
3. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Gossop M, Stewart D, Treacy S, Marsden J, Addiction 2001 97 39 47
4. The quantification of mortality resulting from the regular use of illicit opiates. Hulse GK, English DR, Milne E, Holman CD, Addiction 1999 94 221 229 10.1046/j.1360-0443.1999.9422216.x 10396790
5. Opiates, cocaine and alcohol combinations in drug overdose deaths in New York City, 1990-98. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K, Addiction 2003 98 6 739 747 10.1046/j.1360-0443.2003.00376.x 12780362
6. Illicit drug use in new york city. Paone D, Heller D, Olson C, Kerker B, NYC Vital Signs 2010 9 1 1 4 http://www.nyc.gov/html/doh/downloads/pdf/survey/ survey-2009drugod.pdf
7. Unintentional drug overdose deaths continue to increase; now second leading cause of unintentional deaths. Center for Substance Abuse Research (CESAR), CESAR FAX 2011 20 19 1
8. Unintentional poisoning deaths - United States, 1999-2004. Centers for Disease Control and Prevention, MMWR Morbid Mortal Wkly Rep 2007 56 5 93 96
9. Centers for Disease Control and Prevention National Center for Injury Prevention and Control, Unintentional drug poisoning in the United States CDC, Atlanta, GA 2010 http://www.cdc.gov/HomeandRecreationalSafety/pdf/poison-issue- brief.pdf
10. Substance Abuse and Mental Health Services Administration Office of Applied Studies, Trends in Emergency Department visits involving nonmedical use of narcotic pain relievers The DAWN Report, Rockville, MD 2010 http://www.oas.samhsa.gov/2k10/DAWN016/OpioidED.cfm
11. Substance Abuse and Mental Health Services Administration Office of Applied Studies, The NSDUH Report: Trends in nonmedical use of prescription pain relievers: 2002 to 2007 SAMHSA, Rockville, MD 2009 http://www.oas.samhsa.gov/ 2k9/painRelievers/nonmedicalTrends.pdf
12. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. McCabe SE, Cranford JA, West BT, Addict Behav 2008 33 10 1297 1305 10.1016/j.addbeh.2008.06.005 18632211
13. Johnson BD, Rosenblum A, Kleber H, A White Paper: a new opportunity to expand treatment for heroin users in New York City: Public policy challenges for bringing buprenorphine into drug treatment programs and general medical practice New York City Department of Health and Mental Hygiene, New York, NY 2003 http://www.nyc.gov/html/doh/downloads/pdf/basas/whitepaper.pdf
14. New York City Department of Health and Mental Hygiene, City of New York. Local Governmental Plan Alcohol and Drug Use Services NYC DOHMH, New York, NY 2009 http://www.nyc.gov/html/doh/downloads/pdf/basas/basas-localgovtplan-2009. pdf
15. Office of National Drug Control Policy, National Drug Control Strategy ONDCP, Washington, DC 2010 http://www.whitehousedrugpolicy.gov/publications/ policy/ndcs10/ndcs2010.pdf
16. Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992-2002): Estimation methods and prevalence trends. Cooper HLF, Brady JE, Friedman SR, Tempalski B, Gostnell K, Fom PL, J Urban Health 2008 85 6 826 856 10.1007/s11524-008-9304-9 18709555
17. The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. Wright D, Gfroerer J, Epstein J, NIDA Res Monogr 1997 167 477 497 9243574
18. The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States. Compton WM, Dawson D, Duffy SQ, Grant BF, Am J Psychiatry 2010 167 4 473 75 20360331
19. Substance Abuse and Mental Health Services Administration Office of Applied Studies, Development of computer-assisted interviewing procedures for the National Survey on Drug Abuse SAMHSA, Rockville, MD 2008 http://www.oas.samhsa.gov/NHSDA/CompAssistInterview/toc.htm
20. ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders. ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders. Secondth edition American Society of Addiction Medicine, Inc, Mee-Lee D, Shulman GD, Fishman M, Gastfriend DR, Griffith H, Chevy Chase MD, 2001
21. Diagnostic and statistical manual of mental disorders, 4th American Psychiatric Association, Washington, DC 2000
22. New York State Department of Health, Statewide Planning and Research Cooperative System (SPARCS) NYS DOH, Albany, NY http://www.health.state.ny.us/ statistics/sparcs/operations/overview.htm
23. Substance Abuse and Mental Health Services Administration Office of Applied Studies, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings SAMHSA, Rockville, MD 2011 http://www.oas.samhsa. gov/NSDUH/2k10NSDUH/2k10Results.htm
24. Substance Abuse and Mental Health Services Administration Office of Applied Studies, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, Appendix B SAMHSA, Rockville, MD 2011 http://www.oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm#AppB
25. City of New York Department of Correction, DOC Statistics DOC, New York, NY 2012 http://www.nyc.gov/html/doc/html/stats/doc-stats.shtml
26. Substance Abuse and Mental Health Services Administration Drug Abuse Warning Network (DAWN), Methodology Report SAMHSA, Rockville, MD 2009 http://www.samhsa.gov/data/2k11/DAWN/2009Methods/DAWN2k9-MethodologyReport.htm
27. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Methodological guidelines to estimate the prevalence of problem drug use on the local level EMCDDA, Lisbon 1999
28. Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology. Rehm J, Room R, van den Brink W, Kraus L, Eur Neuropsychopharm 2005 15 4 389 397 10.1016/j.euroneuro.2005.04.004
29. National Quality Forum, National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices National Quality Forum, Washington, DC 2007
30. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R, Drug Alc Depend 2005 77 49 59 10.1016/j.drugalcdep.2004.07.006
31. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6months later. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW, Drug Alc Depend 2009 99 1-3 280 95
32. Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. Domingo-Salvany A, Hartnoll RL, Maguire A, Brugal MT, Albertin P, Cayla JA, Casabona J, Suelves JM, Am J Epidemiol 1998 148 8 732 740 10.1093/oxfordjournals.aje.a009694 9786228
33. Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Hickman M, Cox S, Harvey J, Howes S, Farrell M, Frischner M, Stimson G, Taylor C, Tilling K, Addiction 1999 94 11 1653 1662 10.1046/j.1360-0443.1999.941116534.x 10892005
34. How many dependent heroin users are there in Australia? Hall WD, Ross JE, Lynskey MT, Law MG, Degenhardt LJ, Med J Aust 2000 173 10 528 531 11194736
35. Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia. Hickman M, Hope V, Platt L, Higgins V, Bellis M, Rhodes T, Taylor C, Tilling K, Drug Alcohol Rev 2006 25 2 131 40 10.1080/09595230500537274 16627302
36. Prevalence and detection of illicit drug disorders among hospitalized patients. Stein MD, Wilkinson J, Berglas N, O'Sullivan P, Am J Drug Alcohol Ab 1996 22 3 463 471 10.3109/00952999609001672
37. Clinical vs. laboratory identification of drugs of abuse in patients admitted for acute poisoning. Bjornaas MA, Hovda KE, Mikalsen H, Andrew E, Rudberg N, Ekeberg O, Jacobsen D, Clin Toxicol 2006 44 2 127 134 10.1080/15563650500514384
38. Improving the detection of drug abuse, alcohol abuse, and depression in community health centers. Olfson M, Tobin J, Cassells A, Weissman M, J Health Care Poor U 2003 14 3 386 402 10.1353/hpu.2010.0658
39. The severity of unhealthy alcohol use in hospitalized medical patients: The spectrum is narrow. Saitz RS, Freedner N, Palfai TP, Horton NJ, Samet JH, J Gen Int Med 2006 21 381 85 10.1111/j.1525-1497.2006.00405.x
40. Measuring diagnoses: ICD code accuracy. O'Malley K, Cook K, Price M, Wildes K, Hurdle J, Ashton C, Health Serv Res 2005 40 5 1620 1639 10.1111/j.1475-6773.2005.00444.x 16178999
41. Using administrative data to identify mental illness: what approach is best? Frayne S, Miller D, Sharkansky E, Jackson WV, Wang F, Halanych JH, Berlowitz DR, Kader B, Rosen CS, Keane TM, Am J Med Qual 2010 25 1 42 50 10.1177/1062860609346347 19855046
42. Misclassification of deaths caused by cocaine. Young TW, Pollock DA, An assessment by survey. Am J Foren Med Path 1993 14 1 43 47
43. Coding for mental health and behavioral problems: the arcane elevated to the ranks of the scientific. Rappo P, Pediatrics 2002 110 1 167 168 10.1542/peds.110.1.167 12093964
44. Depression in medical outpatients: Underrecognition and misdiagnosis. Perez-Stable EJ, Miranda J, Munoz RF, Ying YW, Arch Int Med 1990 150 5 1083 88 10.1001/archinte.1990.00390170113024
45. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. Kissin W, McLeod C, Sonnefeld J, Stanton A, J Addict Dis 2006 25 4 91 103.17088229 10.1300/J069v25n04-09 17088229
46. The first three years of buprenorphine in the United States: Experience to date and future directions. Fiellin DA, J Addict Med 2007 1 2 62 67 10.1097/ADM.0b013e3180473c11 21768936
47. Challenges in increasing access to buprenorphine treatment for opiate addiction. West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, Narrow WE, Duffy FF, Regier DA, Am J Addict 2004 13 supp 1 8 16 15204672
48. Screening and brief intervention for unhealthy drug use in primary care settings: Randomized clinical trials are needed. Saitz R, Alford DP, Bernstein J, Cheng DM, Samet J, Palfai T, J Addict Med 2010 4 3 123 130 10.1097/ADM.0b013e3181db6b67 20936079